Table 4.
daf-3 suppresses the expression defects of chemoreceptor genes in daf-7 mutants
| Receptor
|
Neuron
|
% mutants expressing the wild-type patterna
|
|||||
|---|---|---|---|---|---|---|---|
|
daf-7b
|
daf-3b
|
daf-12b
|
daf-2b
|
daf-7; daf-3b
|
daf-7; daf-12bc
|
||
| sra-6 | ASH | 0 | 100 | 100 | 99 | 100 | 6 |
| ASI | 0 | 100 | 0 | 99 | 100 | 0 | |
| str-2 | ASI | 0 | 100 | 0 | 95 | 100 | 45d |
n > 95 for each.
a
Wild-type sra-6 expression is defined as GFP expression in two ASH or ASI neurons. Wild-type str-2 expression is defined as weak or undetectable GFP expression in both ASI neurons.
b
Alleles used were daf-7(el372), daf-3(mgDf90), daf-12(rh61rh411), and daf-2(el370).
c
daf-12(rh61rh411) fully suppressed the Daf-c phenotype, but not the small body size or Egl phenotypes of daf-7 mutants (data not shown).
d
The intensity of GFP expression and the number of animals expressing GFP in the ASI neurons was variable both within and between independent experiments.